Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer

NCT03957252 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

2800

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST: Blood test: ClarityDX Prostate

Sponsor

Nanostics

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]